AtomVie opens $160m radiopharmaceutical manufacturing facility in Ontario

AtomVie has opened a purpose-built radiopharmaceutical manufacturing facility in Hamilton, Ontario, Canada, with an investment of over $160m. The site supports low-to-high throughput production and increases AtomVie's manufacturing capacity more than tenfold. Ribbon-cutting at the opening of AtomVie Global Radiopharma’s purpose-built radiopharmaceutical manufacturing facility. Credit: AtomVie Global Radiopharma / PRNewswire. AtomVie Global Radiopharma has opened a purpose-built radiopharmaceutical manufacturing facility in Hamilton, Ontario, Canada, with an investment of more than $160m. The 72,300ft² site is said to be the largest single-site contract development and manufacturing organisation (CDMO) facility in North America for radiopharmaceutical development to date. LOA and PTSR Model…

Source: Pharmaceutical Technology